Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AA4500 injections for Dupuytren's contracture
ACTRN12607000217404Phase 3Not yet recruiting
- Sponsor
- Auxilium Pharmaceuticals, Inc.
- Start
- Jul 2007
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of collagenase clostridium histolyticum in Dupuytren's contracture, sponsored by Auxilium Pharmaceuticals, Inc. Primary endpoints: Safety assessed by adverse events, vital signs, and grip strength of treated hand, Safety assessed by clinical laboratory tests and 2 more. Planned start Jul 2007; status: not yet recruiting.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on ACTRN12607000217404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000217404.